Condition: Pelvic Cancer · Ovarian Cancer · Cervical Cancer · Sponsor: Universitaire Ziekenhuizen KU Leuven
In a transvaginal tru-cut biopsy, guided by ultrasound, a needle is inserted through the vaginal wall into a pelvic lesion and a few pieces of tissue are obtained for examination. This clinical trial is organized to evaluate the safety and efficacy of transvaginal tru-cut biopsy in a large group of patients with tumors in the small pelvis.
This description comes directly from the study's public registry record.
Wouter Froyman, MD, PHD · +3216344202 · wouter.froyman@uzleuven.be
Stefan Timmerman, MD · stefan.timmerman@uzleuven.be
Always discuss trial participation with your own doctor first.
| UZ Leuven | Leuven, Belgium | Recruiting |
| First Faculty of Medicine, Charles University | Prague, Czechia | Not Yet Recruiting |
| Fondazione Policlinico Universitario A. Gemelli, IRCSS | Rome, Italy | Not Yet Recruiting |
| Department of Clinical Science and Education, Karolinska Institutet and Department of Obstetrics and Gynecology, Södersjukhuset | Stockholm, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05610501